Medigen Biotechnology Corp.

  • About us
    • About us
    • History
    • Corporate milestones
    • Leadership
  • R&D
    • Clinical trials
    • R&D achievements
    • Collaborations
    • Subsidiaries
  • News
    • Press releases
    • Events
  • ESG
  • Investors
    • Corporate governance
    • Financials
    • Shareholder services
    • Material information
    • FAQs
  • Careers
    • Join us
    • Learning and development
    • Compensation and benefit
    • Sustainable talents
  • Contact
  • 繁體中文
  • 簡體中文
  • English

Press Releases

  • 2019/10/07 Medigen Teams Up with Japan's MEDINET to Expand Cell Therapy Market in Taiwan MORE
  • 2019/03/06 Medigen Vaccine Biologics, Medigen Biotechnology, and Taiwan Bio Therapeutics Form PIC/S GMP Cell Therapy Strategic Alliance MORE
  • 2019/01/28 E-Da Healthcare and Medigen Sign MOU on Cell Therapy Collaboration MORE
  • 2019/01/28 CellMax Life to Provide Blood Test for Medigen Biotech's Colorectal Cancer Cell Therapy Clinical Trials MORE
  • 2017/10/31 TBG Biotechnology First to Receive China FDA Approval for High Resolution HLA Genotyping for Hematopietic Cell Transplantation MORE
  • 2017/10/19 MVC co-organized international forum for dengue prevention and vaccine development MORE
  • 2017/09/08 Winston receives the Excellence Award for 2016 Government Uniform Invoice (GUI) — Issuing Business Operator from the Ministry of Finance(MOF), Taiwan MORE
  • 2017/09/08 A Phase III Trial of Muparfostat (PI-88) as Adjuvant Therapy in Patients with Hepatitis Virus Related Hepatocellular Carcinoma (HV-HCC) after Resection MORE
  • 2017/08/08 TBG ExProbe™ Real Time PCR Based Typing Kit receives Taiwan FDA approval and CE Mark, immediately opens markets MORE
  • 2017/08/08 MVC obtains TFDA's approval to initiate EV71 vaccine's phase III Clinical Trial MORE
  • 1
  • 2
  • 3
  • 4

About us

  • About us
  • History
  • Corporate milestones
  • Leadership

R&D

  • Clinical trials
  • R&D achievements
  • Collaborations
  • Subsidiaries

News

  • Press releases
  • Events

ESG

Investors

  • Corporate governance
  • Financials
  • Shareholder services
  • Material information
  • FAQs

Careers

  • Join us
  • Learning and development
  • Compensation and benefit
  • Sustainable talents

Contact

  • Privacy Policy
  • Cookie Policy
Copyright © 2025 Medigen Biotechnology Corp. All Rights Reserved.